Movano's Cash Dwindles Amidst Going Concern Doubts Despite Q2 Loss Reduction

TL;DR

**Movano is burning cash fast and needs to raise capital ASAP, or it's lights out for MOVE investors.**

AI Summary

Movano Inc. (MOVE) reported a net loss of $3.225 million for the three months ended June 30, 2025, a significant improvement from the $6.190 million net loss in the same period of 2024. Revenue for the quarter increased to $103 thousand, up from zero in Q2 2024, primarily driven by sales of its Evie Ring. However, for the six months ended June 30, 2025, revenue decreased to $309 thousand from $852 thousand in the prior year. Total costs and expenses for the three months ended June 30, 2025, decreased by 47.4% to $3.363 million from $6.397 million in Q2 2024, largely due to reduced research and development expenses, which fell by 51.8% to $1.401 million. The company's cash and cash equivalents significantly declined to $2.109 million as of June 30, 2025, from $7.902 million at December 31, 2024, and it incurred an accumulated deficit of $156.5 million. Movano terminated its at-the-market (ATM) program in May 2025 after raising approximately $9.3 million, and management explicitly stated that current cash will not be sufficient to fund projected operating requirements beyond 2025, raising substantial doubt about its ability to continue as a going concern.

Why It Matters

Movano's precarious financial position, highlighted by a $2.109 million cash balance and an explicit going concern warning, signals extreme risk for investors. The company's ability to continue operations beyond 2025 is highly dependent on securing additional financing, which could lead to significant dilution for existing shareholders if achieved through equity offerings. For employees, this raises job security concerns, while customers of the Evie Ring face uncertainty regarding long-term product support and future updates. In the competitive health tech market, Movano's struggle to commercialize its products and achieve profitability puts it at a severe disadvantage against better-capitalized rivals.

Risk Assessment

Risk Level: high — Movano explicitly states that its cash and cash equivalents of $2.109 million as of June 30, 2025, will not be sufficient to fund projected operating requirements beyond 2025, raising "substantial doubt about the Company's ability to continue as a going concern." The accumulated deficit stands at $156.5 million, and net cash used in operating activities for the six months ended June 30, 2025, was $7.399 million, indicating a rapid cash burn.

Analyst Insight

Investors should avoid Movano Inc. (MOVE) given the explicit going concern warning and rapid depletion of cash. The high risk of further dilution or potential bankruptcy makes it an unsuitable investment until the company secures substantial, long-term financing and demonstrates a clear path to profitability.

Financial Highlights

debt To Equity

N/A

revenue

$103K

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

-$3.225M

eps

N/A

gross Margin

N/A

cash Position

$2.109M

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• $2.109M — Cash and Cash Equivalents (Decreased from $7.902M at Dec 31, 2024, insufficient to fund operations beyond 2025.)
• $156.5M — Accumulated Deficit (Increased from $148.107M at Dec 31, 2024, indicating continued losses.)
• $3.225M — Net Loss (Q2 2025) (Improved from $6.190M in Q2 2024, but still a significant loss.)
• $103K — Revenue (Q2 2025) (Increased from $0 in Q2 2024, driven by Evie Ring sales.)
• $7.399M — Net Cash Used in Operating Activities (6 months) (Indicates significant cash burn, contributing to liquidity concerns.)
• 51.8% — R&D Expense Decrease (Q2 YoY) (Reduced to $1.401M from $2.907M, contributing to lower overall expenses.)
• 8,349,080 — Common Stock Shares Outstanding (As of September 22, 2025, indicating potential for further dilution.)
• $9.3M — ATM Program Proceeds (Gross proceeds from at-the-market issuance program, now terminated.)

Key Players & Entities

• Movano Inc. (company) — registrant
• Movano Health (company) — dba name
• Evie Ring (product) — primary revenue-generating product
• United States Securities and Exchange Commission (regulator) — filing recipient
• $2.109 million (dollar_amount) — cash and cash equivalents as of June 30, 2025
• $156.5 million (dollar_amount) — accumulated deficit as of June 30, 2025
• $3.225 million (dollar_amount) — net loss for three months ended June 30, 2025
• $103 thousand (dollar_amount) — revenue for three months ended June 30, 2025
• $7.399 million (dollar_amount) — net cash used in operating activities for six months ended June 30, 2025
• Chief Executive Officer (person) — Chief Operating Decision Maker (CODM)

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: Management explicitly stated that current cash is insufficient to fund projected operating requirements beyond 2025. This raises substantial doubt about the company's ability to continue as a going concern.
• Deteriorating Liquidity [high — financial]: Cash and cash equivalents decreased significantly to $2.109 million as of June 30, 2025, from $7.902 million at December 31, 2024. This sharp decline, coupled with ongoing net losses, exacerbates liquidity concerns.
• Persistent Accumulated Deficit [medium — financial]: The company has an accumulated deficit of $156.5 million as of June 30, 2025, indicating a history of unprofitability. This deficit grew from $148.107 million at the end of 2024.
• Dependence on New Product Success [medium — operational]: Revenue generation is heavily reliant on the Evie Ring, with Q2 2025 revenue of $103K driven by its sales. The success and market adoption of this single product are critical for future revenue growth.
• Limited Access to Capital [medium — financial]: The termination of the at-the-market (ATM) program in May 2025 after raising $9.3 million suggests potential difficulties in raising further capital through equity issuances.
• Reduced R&D Investment [low — operational]: Research and development expenses decreased by 51.8% to $1.401 million in Q2 2025. While this reduced costs, it could impact future product innovation and competitiveness.

Industry Context

Movano operates in the wearable technology and digital health sector, a rapidly growing but highly competitive market. Key trends include the increasing demand for health monitoring devices and the integration of AI for personalized health insights. However, the sector faces challenges related to regulatory approvals for medical-grade devices, data privacy concerns, and intense competition from established tech giants and specialized health companies.

Regulatory Implications

As a company developing health-related devices, Movano is subject to stringent regulatory oversight, particularly from bodies like the FDA if its products are classified as medical devices. Compliance with data privacy regulations (e.g., HIPAA) is also critical. Failure to meet these regulatory standards can lead to significant delays, fines, and reputational damage.

What Investors Should Do

1. Monitor Cash Burn and Runway
2. Evaluate Evie Ring Traction
3. Assess Path to Profitability
4. Scrutinize Future Financing Plans

Key Dates

• 2025-06-30: End of Q2 2025 — Reported $3.225M net loss, $103K revenue, and $2.109M cash. Management indicated insufficient cash beyond 2025.
• 2025-05-31: ATM Program Terminated — Raised approximately $9.3 million, but its termination signals potential capital raising challenges.
• 2024-06-30: End of Q2 2024 — Reported $6.190M net loss and $0 revenue, providing a basis for Q2 2025 performance comparison.
• 2024-12-31: End of Fiscal Year 2024 — Reported $7.902M cash and cash equivalents, and an accumulated deficit of $148.107M.

Glossary

At-the-Market (ATM) Program

A type of equity offering where a company sells its shares directly into the open market over a period of time. (Movano raised $9.3 million through this program, which has now been terminated, impacting its ability to raise further capital.)

Going Concern

An accounting assumption that a business will continue to operate for the foreseeable future. (Management's statement about insufficient cash beyond 2025 raises substantial doubt about Movano's ability to continue as a going concern.)

Accumulated Deficit

The cumulative net losses of a company since its inception, representing the total amount by which expenses have exceeded revenues. (Movano's significant and growing accumulated deficit of $156.5 million highlights its long-term unprofitability.)

Net Loss

The total expenses incurred by a company exceed its total revenues over a specific period. (Movano reported a net loss of $3.225 million for Q2 2025, indicating ongoing operational losses.)

Year-Over-Year Comparison

Movano Inc. has shown a significant improvement in its net loss for Q2 2025, decreasing to $3.225 million from $6.190 million in the prior year's quarter, and has begun generating revenue ($103K) from its Evie Ring, a stark contrast to zero revenue in Q2 2024. However, this positive revenue trend for the quarter is offset by a decrease in year-to-date revenue. Total costs and expenses have been substantially reduced by 47.4%, largely due to a 51.8% cut in R&D spending. Despite these cost controls and initial revenue, the company's cash position has deteriorated significantly, leading to a critical going concern warning, a risk that was not as pronounced in the prior year's filings.

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share MOVE The Nasdaq Stock Market

Filing Documents

• ea0253662-10q_movano.htm (10-Q) — 1072KB
• ea025366201ex31-1_movano.htm (EX-31.1) — 10KB
• ea025366201ex31-2_movano.htm (EX-31.2) — 10KB
• ea025366201ex32-1_movano.htm (EX-32.1) — 5KB
• 0001213900-25-091181.txt ( ) — 5901KB
• move-20250630.xsd (EX-101.SCH) — 42KB
• move-20250630_cal.xml (EX-101.CAL) — 34KB
• move-20250630_def.xml (EX-101.DEF) — 204KB
• move-20250630_lab.xml (EX-101.LAB) — 398KB
• move-20250630_pre.xml (EX-101.PRE) — 223KB
• ea0253662-10q_movano_htm.xml (XML) — 1037KB

– FINANCIAL

PART I – FINANCIAL INFORMATION 1

Financial

Item 1. Financial 1

Management's

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20

Quantitative

Item 3. Quantitative and Qualitative Disclosure About Market Risk 28

Controls and

Item 4. Controls and Procedures 28

– OTHER

PART II – OTHER INFORMATION 29

Legal Proceedings

Item 1. Legal Proceedings 29

Risk Factors

Item 1A. Risk Factors 29

Recent Sales

Item 2. Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities 30

Defaults Upon

Item 3. Defaults Upon Senior Securities 30

Mine Safety

Item 4. Mine Safety Disclosures 30

Other Information

Item 5. Other Information 30

Exhibits

Item 6. Exhibits 31

SIGNATURES

SIGNATURES 32 EXHIBIT INDEX i PART I – FINANCIAL INFORMATION Item 1. Financial Statements Movano Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (Unaudited) June 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 2,109 $ 7,902 Payroll tax credit, current portion 52 52 Vendor deposits 8 28 Inventory 2,479 2,046 Prepaid expenses and other current assets 238 362 Total current assets 4,886 10,390 Property and equipment, net 157 213 Right-of-use asset 509 600 Other assets 108 117 Total assets $ 5,660 $ 11,320 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 2,791 $ 2,016 Deferred revenue 5 36 Other current liabilities 831 1,393 Total current liabilities 3,627 3,445 Noncurrent liabilities: Other noncurrent liabilities 396 520 Total noncurrent liabilities 396 520 Total liabilities 4,023 3,965 Commitments and contingencies (Note 10) Stockholders' equity: Preferred stock, $ 0.0001 par value, 5,000,000 shares authorized at June 30, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024 — — Common stock, $ 0.0001 par value, 500,000,000 shares authorized at June 30, 2025 and December 31, 2024; 8,301,204 and 6,840,291 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 10 10 Additional paid-in capital 158,137 155,452 Accumulated deficit ( 156,510 ) ( 148,107 ) Total stockholders' equity 1,637 7,355 Total liabilities and stockholders' equity $ 5,660 $ 11,320 See accompanying notes to condensed consolidated financial statements. 1 Movano Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss (in thousands, except share and per share data) (Unaudited) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Revenue $ 103

View Full Filing

View this 10-Q filing on SEC EDGAR